Dence CS - Search Results

1

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Dehdashti F, Laforest R, Gao F, Aft RL, Dence CS, Zhou D, Shoghi KI, Siegel BA, Katzenellenbogen JA, Welch MJ. Dehdashti F, et al. Among authors: dence cs. J Nucl Med. 2012 Mar;53(3):363-70. doi: 10.2967/jnumed.111.098319. Epub 2012 Feb 13. J Nucl Med. 2012. PMID: 22331216 Free PMC article.

2

Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.

Oyama N, Ponde DE, Dence C, Kim J, Tai YC, Welch MJ. Oyama N, et al. J Nucl Med. 2004 Mar;45(3):519-25. J Nucl Med. 2004. PMID: 15001697 Free article.

3

Positron tomographic assessment of androgen receptors in prostatic carcinoma.

Dehdashti F, Picus J, Michalski JM, Dence CS, Siegel BA, Katzenellenbogen JA, Welch MJ. Dehdashti F, et al. Among authors: dence cs. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):344-50. doi: 10.1007/s00259-005-1764-5. Epub 2005 Feb 22. Eur J Nucl Med Mol Imaging. 2005. PMID: 15726353 Clinical Trial.

4

Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.

Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P. Welch MJ, et al. Among authors: dence cs. J Nucl Med. 2006 Apr;47(4):689-97. J Nucl Med. 2006. PMID: 16595504 Free article.

5

18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate.

Ponde DE, Dence CS, Oyama N, Kim J, Tai YC, Laforest R, Siegel BA, Welch MJ. Ponde DE, et al. Among authors: dence cs. J Nucl Med. 2007 Mar;48(3):420-8. J Nucl Med. 2007. PMID: 17332620 Free article.

6

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

Fowler AM, Chan SR, Sharp TL, Fettig NM, Zhou D, Dence CS, Carlson KE, Jeyakumar M, Katzenellenbogen JA, Schreiber RD, Welch MJ. Fowler AM, et al. Among authors: dence cs. J Nucl Med. 2012 Jul;53(7):1119-26. doi: 10.2967/jnumed.112.103465. Epub 2012 Jun 5. J Nucl Med. 2012. PMID: 22669982 Free PMC article.

7

Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Chan SR, Fowler AM, Allen JA, Zhou D, Dence CS, Sharp TL, Fettig NM, Dehdashti F, Katzenellenbogen JA. Chan SR, et al. Among authors: dence cs. Clin Cancer Res. 2015 Mar 1;21(5):1063-70. doi: 10.1158/1078-0432.CCR-14-1715. Epub 2014 Dec 17. Clin Cancer Res. 2015. PMID: 25520392 Free PMC article.

8

A PET-compatible tissue bioreactor for research, discovery, and validation of imaging biomarkers and radiopharmaceuticals: system design and proof-of-concept studies.

Whitehead TD, Nemanich ST, Dence C, Shoghi KI. Whitehead TD, et al. J Nucl Med. 2013 Oct;54(10):1812-9. doi: 10.2967/jnumed.113.119776. Epub 2013 Aug 26. J Nucl Med. 2013. PMID: 23978447 Free PMC article.

9

Carbon-11-labeled estrogens as potential imaging agents for breast tumors.

Dence CS, Napolitano E, Katzenellenbogen JA, Welch MJ. Dence CS, et al. Nucl Med Biol. 1996 May;23(4):491-6. doi: 10.1016/0969-8051(96)00029-7. Nucl Med Biol. 1996. PMID: 8832705

10

Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline.

Zhang J, Xu M, Dence CS, Sherman EL, McCarthy TJ, Welch MJ. Zhang J, et al. Among authors: dence cs. J Nucl Med. 1997 Aug;38(8):1273-8. J Nucl Med. 1997. PMID: 9255165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters